Prevention and Treatment of Corneal Neovascularization: Comparison of Different Doses of Subconjunctival Bevacizumab with Corticosteroid in Experimental Rats

Publisher： Karger

E-ISSN： 1423-0259|42|2|90-95

ISSN： 0030-3747

Source： Ophthalmic Research, Vol.42, Iss.2, 2009-06, pp. : 90-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of Corneal Neovascularization: Comparison of Different Doses of Subconjunctival Bevacizumab with Its Topical Form in Experimental Rats

By  

Ophthalmic Research, Vol. 46, Iss. 1, 2011-01 ,pp. : 50-54

Karger

Access to resources Recommend Favorite

Topical and Subconjunctival Bevacizumab for Corneal Neovascularization in an Experimental Rat Model

By  

Ophthalmic Research, Vol. 48, Iss. 3, 2012-04 ,pp. : 118-123

Karger

Access to resources Recommend Favorite

Effect of Subconjunctival and Intraocular Bevacizumab Injections on Corneal Neovascularization in a Mouse Model

By Avisar Inbal   Weinberger Dov   Kremer Israel  

Current Eye Research, Vol. 35, Iss. 2, 2010-02 ,pp. : 108-115

Informa Healthcare

Access to resources Recommend Favorite

Pterygia: Pathogenesis and the Role of Subconjunctival Bevacizumab in Treatment

By Mauro John   Foster C. Stephen  

Seminars in Ophthalmology, Vol. 24, Iss. 3, 2009-05 ,pp. : 130-134

Informa Healthcare

Access to resources Recommend Favorite

Antineovascular Effect of α-Interferonon Corneal Neovascularization in Rats

By Öztürk Faruk   Sobaci Güngör   Ilker S. Sami   Can Cevat  

Annals of Ophthalmology, Vol. 33, Iss. 1, 2001-03 ,pp. : 35-39

Humana Press, Inc

Access to resources Recommend Favorite